The photopic negative response of the blue-on-yellow flash-electroretinogram in glaucomas and normal subjects.

The photopic negative response of the flash-electroretinogram driven by the middle- and long-wavelength cones has been shown to be reduced in non-human primates with experimental glaucoma and in human patients with glaucoma. The photopic negative response for the blue-sensitive response has been studied using a blue-green silent-substitution-technique on a red background. The aim of this study was to re-evaluate the value of the photopic negative response of the blue-sensitive pathway in glaucoma using a conventional flash-electroretinogram. In 37 eyes of 37 controls (age: 53 +/- 13.6 years) and 37 eyes of 37 patients with open-angle glaucoma of different perimetric visual field defects (age: 58.3 +/- 10 years; MD: 11.7 +/- 6.7 dB) of the Erlangen glaucoma registry Ganzfeld flash-electroretinograms (LKC, UTAS 3000) were recorded using blue Xenon-flashes of increasing photopic luminance (0.013, 0.018, 0.030, and 0.052 cd s/m(2); 440 nm) on a bright yellow background (238 cd/m(2); 550 nm) after 2 min of light adaptation. Amplitudes and implicit times of the photopic negative response and of L&M-cone- and S-cone-driven b-waves were compared between glaucomas and controls for all flash energies (unpaired t-test). The amplitudes of the photopic negative response were significantly reduced in glaucoma patients for all flash energies (P < 0.001). The implicit times of L&M-cone-driven b-wave (0.013, 0.018, 0.030, and 0.052 cd s/m(2)) and S-cone-driven b-wave (0.030 and 0.052 cd s/m(2)) were significantly prolonged in glaucoma patients (P < 0.05). The changes in these implicit times, however, are very small (1.5 ms or less). The other measures did not differ significantly. The amplitude of the photopic negative response and the implicit times of the L&M-cone and S-cone b-wave in the same responses of the blue-on-yellow flash-electroretinogram are potentially useful in the evaluation of inner-retinal function in glaucoma.